InspireMD Announces Live Case Broadcast at ISET 2022 Conference Following the Supplement Approval by the FDA Regarding its Pivotal C-Guardians TrialGlobeNewsWire • 01/18/22
InspireMD, Inc. (NSPAR) CEO Marvin Slosman on Q3 2021 Results - Earnings Call TranscriptSeeking Alpha • 11/09/21
InspireMD Reports Third Quarter 2021 Financial Results and Provides Corporate UpdateGlobeNewsWire • 11/09/21
InspireMD to Report Third Quarter 2021 Financial Results on November 9, 2021 and Provide Corporate Business UpdateGlobeNewsWire • 10/26/21
InspireMD Receives Reimbursement Approval for CGuard™ Embolic Prevention System from the French National Authority for HealthGlobeNewsWire • 10/13/21
InspireMD, Inc. (NSPR) CEO Marvin Slosman on Q2 2021 Results - Earnings Call TranscriptSeeking Alpha • 08/10/21
InspireMD Enrolls and Treats First Patients at Ballad Health System in U.S. Registration C-Guardian Clinical Trial of CGuard EPSGlobeNewsWire • 07/23/21
InspireMD to Present at the LD Micro Virtual Invitational Conference on June 9, 2021GlobeNewsWire • 06/02/21
InspireMD to Participate at the Investor Summit Conference and Present to Investors on May 17, 2021GlobeNewsWire • 05/14/21
InspireMD, Inc. (NSPR) CEO Marvin Slosman on Q1 2021 Results - Earnings Call TranscriptSeeking Alpha • 05/11/21
InspireMD Appoints Acclaimed Interventional Cardiologist Kenneth Rosenfield, MD as Chair of its Newly Formed Scientific Advisory BoardGlobeNewsWire • 04/29/21